USANA not selling
This article was originally published in The Tan Sheet
Executive Summary
Unity Acquisition Corp.'s tender offer of $28 per share of USANA Health Science's stock is "inadequate and not in the best interests of USANA's shareholders," the Salt Lake City-based firm announces July 3. USANA says the special committee of its board of directors "unanimously" determined the firm should reject Unity Acquisition's offer. This is not the first tender offer USANA has received. In May, Gull Holdings offered to acquire USANA's outstanding shares for $26 per share (1"The Tan Sheet" May 26, 2008, In Brief)...You may also be interested in...
USANA for sale
USANA Health Sciences' board formed a special committee of independent directors to evaluate a tender offer expected from Gull Holdings, Ltd. and others, to acquire all of its outstanding shares at $26 per share, USANA says May 20. Gull Holdings indicated its intent in a May 13 notice to the Securities and Exchange Commission...
QUOTED. 19 February 2020. Stephen Hahn.
The US FDA has abandoned all near-term plans to inspect Chinese manufacturing facilities in the wake of the coronavirus crisis. See what agency head Stephen Hahn said about it here.
DevaCurl Faces Multiple Class Actions As Latest Brand Linked To Hair Loss
The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: